| Secondary |
| Product Used For Unknown Indication |
52.1% |
| Rheumatoid Arthritis |
11.6% |
| Hypertension |
6.2% |
| Hypothyroidism |
3.1% |
| Foetal Exposure During Pregnancy |
2.7% |
| Candidiasis |
2.3% |
| Essential Hypertension |
2.3% |
| Parkinson's Disease |
2.3% |
| Respiratory Tract Infection |
2.3% |
| Atrial Fibrillation |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Cerebrovascular Accident Prophylaxis |
1.5% |
| Diabetes Mellitus |
1.5% |
| Glomerulonephritis |
1.5% |
| Ill-defined Disorder |
1.5% |
| Immune Thrombocytopenic Purpura |
1.5% |
| Chronic Hepatitis C |
1.2% |
| Blood Cholesterol Increased |
0.8% |
| Dementia |
0.8% |
| Diverticulitis |
0.8% |
|
| Supraventricular Tachycardia |
20.0% |
| Renal Failure Acute |
13.3% |
| Talipes |
10.0% |
| Hyponatraemia |
6.7% |
| Atrial Fibrillation |
3.3% |
| Drug Dose Omission |
3.3% |
| Haematochezia |
3.3% |
| Liver Injury |
3.3% |
| Pancreatitis |
3.3% |
| Retinopathy |
3.3% |
| Shock Haemorrhagic |
3.3% |
| Somnolence |
3.3% |
| Syncope |
3.3% |
| Tachycardia |
3.3% |
| Upper Gastrointestinal Haemorrhage |
3.3% |
| Vasculitis Cerebral |
3.3% |
| Ventricular Fibrillation |
3.3% |
| Vomiting |
3.3% |
| Weight Decreased |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.5% |
| Hypertension |
12.0% |
| Atrial Fibrillation |
5.7% |
| Pain |
3.7% |
| Cardiac Failure |
3.4% |
| Rheumatoid Arthritis |
3.0% |
| Coronary Artery Disease |
2.8% |
| Cerebrovascular Accident Prophylaxis |
2.6% |
| Diabetes Mellitus |
2.1% |
| Parkinson's Disease |
2.0% |
| Prophylaxis |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Osteoporosis |
1.9% |
| Hyperparathyroidism Secondary |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| B-cell Lymphoma |
1.2% |
| Restless Legs Syndrome |
1.2% |
| Thrombosis Prophylaxis |
1.1% |
| Depression |
1.0% |
| Renal Failure |
0.9% |
|
| Pneumonia |
9.8% |
| Renal Failure |
8.5% |
| Renal Failure Acute |
8.5% |
| Vomiting |
8.5% |
| Syncope |
6.1% |
| Death |
5.5% |
| Renal Impairment |
5.5% |
| Haemoglobin Decreased |
4.9% |
| Sepsis |
4.9% |
| Thrombocytopenia |
4.9% |
| Hallucination |
3.7% |
| Oedema Peripheral |
3.7% |
| Tachycardia |
3.7% |
| Weight Increased |
3.7% |
| International Normalised Ratio Increased |
3.0% |
| Myocardial Infarction |
3.0% |
| Orchitis |
3.0% |
| Pancytopenia |
3.0% |
| Pulse Absent |
3.0% |
| Rhabdomyolysis |
3.0% |
|
| Interacting |
| Hypertension |
17.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
10.6% |
| Back Pain |
8.5% |
| Depression |
8.5% |
| Cancer Pain |
6.4% |
| Product Used For Unknown Indication |
6.4% |
| Coronary Artery Disease |
4.3% |
| Diabetes Mellitus |
4.3% |
| Folate Deficiency |
4.3% |
| Ischaemic Heart Disease Prophylaxis |
4.3% |
| Lipids Increased |
4.3% |
| Pain |
4.3% |
| Analgesic Therapy |
2.1% |
| Cardiac Failure |
2.1% |
| Extrapyramidal Disorder |
2.1% |
| Gastrointestinal Disorder |
2.1% |
| Hyperlipidaemia |
2.1% |
| Initial Insomnia |
2.1% |
| Nephrogenic Anaemia |
2.1% |
| Osteoarthritis |
2.1% |
|
| Drug Interaction |
28.6% |
| Hypokalaemia |
28.6% |
| Hypertensive Crisis |
14.3% |
| Renal Failure Acute |
14.3% |
| Somnolence |
14.3% |
|
